Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convalescent Plasma in the Treatment of COVID 19

NCT04343261 is registered in ClinicalTrials.gov with Trinity Health Of New England as lead sponsor.

NCT NCT04343261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04343261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convalescent Plasma in the Treatment of COVID 19
Lead sponsor
Trinity Health Of New England
Phase
Phase 2
Overall status
Completed
Start date
April 10, 2020
Completion date
August 13, 2020
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid, severe acute respiratory syndrome coronavirus 2 (sars-cov-2)